SickKids Hospital seeing ‘tremendous increase' in e-scooter injuries, doctor says
An emergency room doctor at Toronto's SickKids Hospital says physicians are already seeing a 'tremendous increase' in both the number and severity of e-scooter injuries this year.
Dr. Daniel Rosenfield told CP24 on Tuesday morning that the emergency department at SickKids saw 16 e-scooter injuries in the month of May alone.
Rosenfield said this marks the continuation of a concerning trend that the downtown hospital has seen in recent years.
According to SickKids, there were 16 e-scooter injuries in June and July of last year, up from just five in June and July of 2023.
'We've seen major head injuries, major inter-abdominal injuries, significant fractures,' Rosenfield said.
'The majority of the injuries we've seen are head injuries and 80 per cent of our users have not been wearing helmets when they had these injuries.'
Rosenfield said the most severe injuries included significant facial fractures and internal bleeding. Some resulted in hospital and even ICU admission.
'The speeds that these scooters can reach so quickly, the acceleration that's found within these, much like an electric car, is unlike anything we've ever seen,' he said.
'My six-year-old on his scooter with his foot power cannot get anywhere near the speeds these kids get at two and three seconds.'
Recent hospital data from 2020 to 2024 found that about 25 per cent of patients at SickKids who presented with e-scooter injuries were admitted for serious injuries.
Rosenfield said experts do not recommend e-scooter use for anyone under the age of 16, adding that anyone riding one should wear a helmet to prevent serious injuries in the event of a collision.
'We are really lucky that we haven't seen any fatalities to date, but I honestly think as this trend continues, there is a good possibility that could occur.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
an hour ago
- CTV News
‘Purple Rain Run' returns to support T2B comfort care tote program
Sienna Francis (L) and Paige Wilcox (R) are seen at the 2023 Purple Rain Run in Windsor. (Source: Facebook) The Purple Rain Run returns for a second year in support of the Transition to Betterness (T2B) Dr. Michelle Prince Comfort Care Tote Program. Prince started the tote program back in 2018 by using her own experience with cancer to uplift patients with curated items in each tote as they begin their chemotherapy journey at the Windsor Regional Hospital Cancer Centre. The Purple Rain Run will take place Sunday Aug. 24 at Lakewood Park in Tecumseh. Event co-chair and Prince's daughter, Sienna Francis, said the event is going to be a memorable 5K walk/run where participants will be showered with purple powder, creating a colourful and joyous celebration of life and resilience. 'Last year with the support of our incredible community we raised an astounding $70,000 and we aim to surpass that milestone this year,' Francis said. She said said participants pay an entry fee of $45, which is half the value of the comfort totes that are handed out. 'The Dr. Michelle Prince Comfort Care Tote Program provides high-quality custom tote bags valued at $100 each to patients starting their first appointment for chemotherapy and it's filled with tangible items to help them cope and manage side effects.' she said. 'My mother hand picked these items that were part of the tote that she was given and also added other items that she found beneficial along the way,' added Francis. Event co-chair Paige Wilcox said it means a lot to see people who have been impacted by the program come together for the cause. 'It's means a lot to see everyone come together and bring a sense of awareness, but also, just celebrate a fun day where we can raise money for our passion project that we continue to champion on for Michelle,' Wilcox said. Organizers said they had over 250 participants last year and are looking to surpass that number. — Dustin Coffman & Rob Hindi/AM800 News
CTV News
2 hours ago
- CTV News
Construction begins on Saskatoon's newest supportive housing unit
A prayer and groundbreaking ceremony has been held on the future site of Saskatoon's newest supportive housing unit. The 16 unit, 24 bedroom building will provide a safe space for those removing themselves from abusive situations. The facility is thanks to the Metis Nation of Saskatchewan, alongside partners from all three levels of government. 'We need to remember that our people, our citizens, are distinct and they're unique, and we cannot expect the colonial systems to continue to implement programs and services that are not for them,' said Beverly Fullerton, Minister of Health, Mental Health & Addictions for Metis Nation Saskatchewan. 'With Metis Nation, it's absolutely amazing that we can actually address the issues and then wrap our citizens around that love and care and respect they deserve.' The facility will provide culturally-appropriate services, including childcare, education and round-the-clock support workers. While the space has been curated by Saskatchewan's Metis Nation, the building is open to Metis, Indigenous and non-Indigenous women and children, and members of the 2SLGBTQIA+ community. 'There are no borders. There shouldn't be any borders,' said Glen McCallum, President of Metis Nation Saskatchewan. 'That's why this place is going to be open for Metis, First Nations, Inuit and non-Indigenous folks that are struggling with domestic violence, and to be able to have a safe place to come to.' The location for the building has a special place in the hearts of those on the organizing team. Located in one of Saskatoon's newer neighbourhoods, Kensington, Fullerton says the location will help remove some of the stigma that comes along with supportive housing. 'When we think about our society, we'll normally look at whether it's homeless, domestic violence victims or addictions. There's some weird reason why we assume they need to be in the not-so-great areas of our cities, and so they offer them a space and show they're worthy and they are welcome.' The facility is expected to be operating by fall of 2026. 'We still have a lot of work to do behind the scenes, making sure our programs and supports are going to be addressing the issues,' added Fullerton. 'Things like this, we don't always want to rush them, but we know the need is there. So we'll be doing everything we can to get it open as soon as we can.'
National Post
2 hours ago
- National Post
Health Canada approves Ozempic for kidney protection in Type 2 diabetics
Glomerular filtration rate is a measure that shows how well the kidneys are filtering out waste and excess water. Ozempic is the first GLP-1 drug approved in Canada to protect both kidneys and the heart in patients with Type 2 diabetes, said Ur, noting that the cardiovascular benefits of semaglutide have been extensively studied. 'The benefit of Ozempic is that you also get weight loss, which is a very important goal for most people (with Type 2 diabetes). That's a very exciting combination,' he said. Some people experience gastrointestinal side effects when they take Ozempic, Ur said, including nausea, vomiting, constipation and diarrhea. More severe complications can include gall bladder inflammation and pancreatitis, but most side effects are minor, he said. The benefit of slowing or stopping progressive kidney disease in people with diabetes would outweigh the risks of minor side effects, Ur said. The FLOW trial was conducted in 28 countries, including Canada. The researchers randomized 3,533 people with diabetes and chronic kidney disease to either receive Ozempic or a placebo. The study was conducted between 2019 and early 2024. Participants were followed for an average of 3.4 years to monitor for 'major kidney disease events,' including kidney failure leading to dialysis or transplantation, a 50-per-cent reduction in kidney function measured by glomerular filtration rate, or death from kidney-related or cardiovascular causes. The Ozempic or placebo doses were given to participants on top of other medications they were taking, including drugs to control blood pressure and blood sugar. Although reducing blood pressure and blood sugar have beneficial effects for the kidneys, Cherney said Ozempic appeared to have an additional positive impact on kidney function and future research can help pinpoint how that works. 'Another weapon against kidney disease is incredibly powerful. And these medicines will often turn patients around who are doing very poorly because it addresses so many different issues — the kidney, the cardiovascular, the metabolic, and the weight,' said Cherney. Ur said it's possible Ozempic could play a role in reducing inflammation in the kidneys and that might be one explanation for its positive effect. Regardless of the reason for its effectiveness, he said the FLOW trial and Health Canada's approval reinforces the importance of using the drug 'relatively early in the disease process' to minimize kidney damage in people with Type 2 diabetes. Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here.
